| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.05 |